Public health and biopharma leaders at a recent summit highlighted areas that need attention to be better prepared to tackle the next pandemic and also some key lessons learned as the world struggles to put COVID-19 in the rearview mirror.
Julie Gerberding, CEO of the Foundation for the National Institutes of Health (FNIH) emphasized the need to really understand the concept of “spillover” – the intersections between humans and animals that result in new viruses emerging in people and at times in animals as seen